tirzepatide children Eli Lilly plans diabetes drug trial for kids as young as 6 years, Bloomberg reports Prediction of pediatric dose of

The aim of this study was to develop a transdermal delivery system designed to co-encapsulate carnosine and quercetin, termed EV-QuerCar, thereby enhancing their stability and penetration

As clinical trials reveal its efficacy and safety profile, Tirzepatyd has the potential to revolutionise the obesity management landscape, enabling individuals to embark on a transformative journey towards health

First, data suggest that individuals who discontinue treatment with GLP-1 RAs are likely to regain a considerable portion of the weight lost after starting therapy

This makes biological sense because GLP-1 and GIP receptors are heavily expressed throughout the gut, and activating them directly affects gastric motility, gastric emptying speed, and intestinal function

From inflammatory bowel concerns to leaky gut, digestive problems can be physically painful and emotionally draining